Experimental study about efficacy of treatment for metastatic lung tumor using Matrix Metalloproteinasa Inhibitor An experimental study of pulmonary artery infusion with cisplatin for solitary pulmonary tumor model using rat colorectal adenocarcinoma cell

基质金属蛋白酶抑制剂治疗转移性肺肿瘤疗效的实验研究 顺铂肺动脉灌注大鼠结直肠腺癌细胞孤立性肺肿瘤模型的实验研究

基本信息

  • 批准号:
    09671400
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Objectives : The purpose of this study is to assess an availability of the tumor model made by open lung injection for an experiment about metastatic lung tumor by confirmation of its blood supply, and to evaluate an efficacy of pulmonary artery infusion (PAI) with cisplatin in this model using rat colorectal adenocarcinoma (RCN-9) cell line.Methods : Male F344 rats were used. In experiment 1, rat colorectal adenocarcinoma (RCN-9) cells were injected to the rat left lung on day 0. On day 10, tissue blood flow of the tumors before/after pulmonary arterial occlusion were measured. I experiment 2, RCN-9 cells were injected to the rat left lung, and no other treatment was performed in the control group. The other group was performed PAL with 0.1 mg of cisplatin on day 3. On day 10, all rats were sacrificed and measured the maximum cross sectional areas of the tumors. Results : In experiment 1, the tissue blood flow of the tumors was significantly decreased after the pulmonary. arterial occlusion. In experiment 2, the maximum cross sectional areas of the tumors in the PAI group were significantly lower than those in the control group.Conclusion : The blood flow of the tumor is supplied from pulmonary artery, so this model seems to be useful for the experiment about metastatic lung tumor. The tumor sizes were significantly reduced with PAI in this model. The local chemotherapy with PAI could be an effective choice of therapy for metastatic lung tumor from colorectal adenocarcinoma.
目的:以大鼠结直肠腺癌(RCN-9)细胞株为实验对象,通过确定肺内血供,评价开胸肺内注射肿瘤模型的可行性,并评价顺铂(PAI)对该模型的疗效。实验一将大鼠结肠腺癌(RCN-9)细胞接种于第0天大鼠左肺内。于第10天测定肺动脉阻断前后肿瘤的组织血流量。实验二:将RCN-9细胞注入大鼠左肺,对照组不作其他处理。另一组于第3天给予顺铂0.1 mg,于第10天处死所有大鼠,测量肿瘤最大横截面积。结果:实验1肺切除后肿瘤组织血流量明显减少。动脉闭塞。在实验2中,PAI组肿瘤的最大横截面积明显低于对照组。结论:肿瘤的血流来自于肺动脉,该模型可用于肺转移瘤的实验研究。在该模型中,PAI可显著缩小肿瘤大小。PAI局部化疗可作为结直肠癌肺转移瘤治疗的有效选择。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAITO Yukihito其他文献

SAITO Yukihito的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAITO Yukihito', 18)}}的其他基金

Prophylactic effect of proton pump inhibitor in the development of bronchiolitis obliterans after lung transplantation in rats
质子泵抑制剂对大鼠肺移植术后闭塞性细支气管炎的预防作用
  • 批准号:
    11671346
  • 财政年份:
    1999
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments
走向临床试验:AXL-STAT3 靶向肺肿瘤微环境
  • 批准号:
    10660429
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The Immunomodulatory Effects of Nrf2 Activation on Macrophages in the Lung Tumor Microenvironment
Nrf2 激活对肺肿瘤微环境中巨噬细胞的免疫调节作用
  • 批准号:
    10678092
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of the DREAM complex in the lung tumor suppression
DREAM 复合物在抑制肺部肿瘤中的作用
  • 批准号:
    10575588
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Project 2: Mitigating Lung Cancer Disparities in Native Hawaiians: A Population-Based Approach to Evaluate Prevention Barriers and Lung Tumor Biology
项目 2:减少夏威夷原住民的肺癌差异:基于人群的方法来评估预防障碍和肺癌生物学
  • 批准号:
    10716155
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity
双轴靶向控制肺肿瘤血管生成和免疫
  • 批准号:
    10522763
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Project 3: Multispectral Imaging and Robotic Bronchoscopy Devices for Precision Lung Tumor Detection
项目3:用于精准肺部肿瘤检测的多光谱成像和机器人支气管镜设备
  • 批准号:
    10647652
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Project 3: Multispectral Imaging and Robotic Bronchoscopy Devices for Precision Lung Tumor Detection
项目3:用于精准肺部肿瘤检测的多光谱成像和机器人支气管镜设备
  • 批准号:
    10333066
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity
双轴靶向控制肺肿瘤血管生成和免疫
  • 批准号:
    10674889
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Profiling immune cells in aged lung tumor initiation
分析老年肺肿瘤发生过程中的免疫细胞
  • 批准号:
    10830688
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
The Lung Tumor Microenvironment: Role of Resident Pulmonary Vascular Progenitor Cells in Cancer Progression and Metastasis
肺肿瘤微环境:常驻肺血管祖细胞在癌症进展和转移中的作用
  • 批准号:
    10097362
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了